Cancer Radiotherapie

简称 CANCER RADIOTHER ·FRANCE ·出版周期 Bimonthly ·年均收录 122 篇

1.4

最新影响因子

40.50%

自引率

容易来源Elsevier官网：64%

投稿难度

偏慢,4-8周来源Elsevie...

审稿周期

期刊简介

Cancer Radiotherapie是一本专注于放射肿瘤学领域的学术期刊，其ISSN号为1278-3218。该杂志由Elsevier出版商出版，出版地为法国，出版周期为双月刊。根据最新数据，其影响因子较低，未进入SCI核心期刊目录，也未在中科院分区中明确列出。杂志为非开放获取（非OA）期刊，主要发表与放射治疗相关的临床和基础研究，涵盖肿瘤放射治疗技术、剂量学、副作用管理及多学科综合治疗等领域。其发文特点包括注重临床实践与技术创新，但影响力有限，可能因未被SCI收录而影响国际传播。投稿时需注意其学术影响力较低，可能对职业晋升或学术评价的帮助有限，但适合专注于放射治疗领域的学者交流。

影响因子趋势

近期发表

Differential diagnosis of imaging alterations after stereotactic radiotherapy of brain metastases: A narrative review 2026-08-12

Comparative study of interstitial brachytherapy and intensity-modulated radiotherapy as tumour bed boost after conservative surgery for breast cancer: Toxicity and cosmetic outcomes 2026-07-03

Contribution of fluorodeoxyglucose positron-emission tomography combined with magnetic resonance imaging for differential diagnosis between radionecrosis and recurrence of treated brain metastasis 2026-07-07

The place of radiotherapy in the treatment of inflammatory breast cancer: Practical questions and responses 2026-08-07

Editorial Board 2026-08-26

Erratum to “Successful identification and management of a stroke-like migraine attacks after radiation therapy syndrome occurring 36 years after cranial irradiation” [Cancer Radiother 29 (2025) 104618] 2026-08-07

Efficiency and equity in radiotherapy accessibility and availability in France 2026-07-29

Radiation-induced oral mucositis: Correlation between clinician-assessed WHO grades and patient-reported outcomes, an exploratory prospective observational pilot study 2026-08-07

Long-term control after stereotactic body radiotherapy for perineal recurrence of prostate cancer after radical prostatectomy and radiotherapy: A case report and review of the literature 2026-08-12

Organs at risk radiation dose constraints: 2025 update 2026-08-07